Review Article
Current Status of Alginate in Drug Delivery
Table 2
Alginate nano/microparticles with protein content.
| Protein types | Polymer | Method for encapsulation | Significant findings | References |
| Salmonella effector enzyme (AvrA) | Alginate-chitosan | Microfluidics | Capable of releasing AvrA NPs in the small intestine and colon | [97] | Silk fibroin | Alginate and PLGA | Layer-by-layer deposition | Silk coatings provide stable-encapsulated protein | [98] | Bovine serum albumin | Alginate-poloxamer | Spray drying | Spherical in shape with a size range of 4–6 μm and faster protein release | [99] | Bovine serum albumin | Alginate | Microemulsions-based reactors | Microemulsions of 6 nm stabilized the protein | [100] | Dextran-HEMA | Alginate | Partial oxidation | Good gelling ability | [101] |
|
|